Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Nederland
  4. Euronext Amsterdam
  5. Galapagos NV
  6. Nieuws
  7. Andere talen
    GLPG   BE0003818359

GALAPAGOS NV

(GLPG)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op GALAPAGOS NV
06/10GALAPAGOS : presents new data from the SELECTION Phase 3 program at the United European Ga..
06/10GALAPAGOS : announces completion of patient enrollment for DIVERSITY Phase 3 study with fi..
04/10GALAPAGOS : presents new data from the SELECTION Phase 3 program at the United European Ga..
04/10Galapagos Presents New Data from the Selection Phase 3 Program At the United European G..
04/10GALAPAGOS : Completes Patient Recruitment In Late-Stage Inflammatory Bowel Disease Study
04/10GALAPAGOS : announces completion of patient enrollment for DIVERSITY Phase 3 study with fi..
04/10Galapagos Announces Completion of Patient Enrollment for Diversity Phase 3 Study with F..
21/09GALAPAGOS : increases share capital through subscription right exercises (Form 6-K)
21/09GALAPAGOS : N.V., - Galapagos increases share capital through subscription right exercises
21/09GALAPAGOS : Issues New Shares For Subscription Right Exercises
20/09GALAPAGOS : increases share capital through subscription right exercises
20/09GALAPAGOS : ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECAģ (FILGOTINIB) FOR THE TREATMENT O..
17/09GALAPAGOS : N.v., - galapagos announces positive chmp opinion for jyselecaģ (filgotinib) f..
17/09GALAPAGOS : Gets European Medicines Agency's Positive Opinion on Ulcerative Colitis Drug C..
17/09GALAPAGOS : Says it Received European Medicines Agency Positive Opinion for Ulcerative Col..
17/09GALAPAGOS : Announces positive chmp opinion for jyselecaģ (filgotinib) for the treatment o..
17/09Galapagos Announces Positive CHMP Opinion for Jyselecaģ for the Treatment of Adults wit..
01/09GALAPAGOS NV : - Bionity - Galapagos announces planned retirement of CEO
01/09El apoyo, cuando nos retienen
31/08GALAPAGOS : announces planned retirement of CEO (Form 6-K)
31/08Galapagos NV Announces Retirement of CEO Onno Van De Stolpe
31/08VISIÓN GENERAL DE LOS ETFS : ° Ámster-tadam !
30/08ADRs Close Mostly Higher; Alibaba, Shell Trade Actively
30/08GALAPAGOS : CEO To Retire
30/08GALAPAGOS : announces planned retirement of CEO
30/08Galapagos NV CEO to Retire
30/08TOUR D'HORIZON DES ETF : Amster-tadam !
19/08GALAPAGOS : Shares Drop After Barclays Downgrade
19/08Le changement, c'est bientôt
19/08AVIS D'ANALYSTES DU JOUR : LVMH, Kering, Teleperformance, Galapagos, Carlsberg, Swatch, Le..
18/08Six actions infréquentables en 2021
09/08Resultados casi perfectos
09/08Des résultats presque parfaits
09/08AVIS D'ANALYSTES DU JOUR : Crédit Agricole, Stellantis, Daimler, Galapagos, Swissquote, IM..
05/08Galapagos Nv Reports Earnings Results for the Second Quarter Ended June 30, 2021
05/08GALAPAGOS : reports H1 financial results with refocused pipeline and operational progress
15/07Galapagos ADRs Down After Study Data
15/07SECTOR UPDATE : Health Care Stocks Flat To Lower Pre-Bell Thursday
15/07UPDATE : Galapagos Reports Results From Phase 1b Psoriasis Study -- Shares Slump in Pre-Ma..
15/07GALAPAGOS NV : des résultats cliniques décevants
15/07GALAPAGOS : N.V., - Galapagos reports positive topline results with selective TYK2 inhibit..
15/07GALAPAGOS : N.V., - Galapagos demonstrates early clinical activity with SIK2/3 inhibition ..
15/07GALAPAGOS : données de phase Ib positives en psoriasis
15/07GALAPAGOS : Drug Shown Safe In Three Clinical Studies
15/07GALAPAGOS' : Psoriasis Drug Shown Safe, Well-Tolerated in Early-Stage Study
14/07GALAPAGOS : demonstrates early clinical activity with SIK2/3 inhibition in inflammation (F..
14/07GALAPAGOS : reports positive topline results with selective TYK2 inhibitor GLPG3667 in Pha..
14/07GALAPAGOS : GLPG3667 Shows Positive Results in Psoriasis Patients, Reports Topline Results..
14/07GALAPAGOS : demonstrates early clinical activity with SIK2/3 inhibition in inflammation
14/07GALAPAGOS : reports positive topline results with selective TYK2 inhibitor GLPG3667 in Pha..
14/07Galapagos NV Demonstrates Early Clinical Activity with SIK2/3 Inhibition in Inflammatio..
14/07Galapagos NV Reports Positive Topline Results with Selective TYK2 Inhibitor Glpg3667 in..
12/07GALAPAGOS : Bowel Disease Drug Shows Effect In Post-Hoc Analyses Of Late-Stage Study
10/07GALAPAGOS : announces new data supporting rapid symptom improvement and sustained steroid-..
10/07Galapagos Announces New Data Supporting Rapid Symptom Improvement and Sustained Steroid..
23/06GALAPAGOS : announces departure of CSO Piet Wigerinck later this year (Form 6-K)
23/06GALAPAGOS : Chief Scientific Officer To Step Down
22/06GALAPAGOS : Chief Scientific Officer to Leave Company Later This Year
22/06Galapagos Announces Departure of CSO Piet Wigerinck
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P Global 1200
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P International 700
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P EUROPE 350 - Pharmaceuticals, Biotechnology &..
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P EUROPE 350 - Health Care
21/06GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P EUROPE 350
08/06GALAPAGOS : increases share capital through subscription right exercises (Form 6-K)
07/06Galapagos increases share capital through subscription right exercises
04/06GALAPAGOS : SELECTION study on filgotinib in ulcerative colitis published in The Lancet (F..
04/06GALAPAGOS : Anti-inflammatory Drug Jyseleca Sustains Efficacy in Maintenance Study
04/06Galapagos NV Announces That Primary and Secondary Endpoint Results from the Phase 3 SEL..
28/05GALAPAGOS : to present data on rheumatoid arthritis at the upcoming European League Agains..
27/05Galapagos NV to Present Data on Rheumatoid Arthritis At the Upcoming European League Ag..
19/05GALAPAGOS : announces first patient enrolled in FILOSOPHY study to advance understanding o..
19/05GALAPAGOS : Enrolls First Patient in Post-Approval Study of Arthritis Drug
18/05GALAPAGOS : Launches Phase 4 Study of Filgotinib Rheumatoid Arthritis Medication in Europe
18/05Galapagos Announces First Patient Enrolled in FILOSOPHY Study to Advance Understanding ..
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op GALAPAGOS NV
04/11/21